Literature DB >> 18716554

Patterns of brain infiltration and secondary structure formation in supratentorial ependymal tumors.

Norman L Lehman1.   

Abstract

Ependymomas are generally considered to be noninfiltrative tumors that have discrete borders with adjacent brain tissue. Most occur in the posterior fossa or spinal cord. Supratentorial ependymal tumors arise near the ventricular system or, more rarely, within the cerebral white matter or cortex. Presented here are 6 supratentorial ependymal tumors, 3 that primarily involve the cerebral cortex and 3 that extend into the cortex from the underlying white matter. By microscopy, all of these tumors locally infiltrate the cortex and/or white matter along small blood vessels and axonal fiber tracts. They also form other glioma secondary structures including perineuronal tumor cell satellitosis and subpial tumor cell mounds. The 3 cortical ependymal tumors show a spectrum of features ranging from conventional and clear-cell ependymoma-like patterns to more angiocentric glioma-like histology. Because ependymal tumors generally have a significantly better prognosis than other infiltrating gliomas, recognition of their capacity to infiltrate adjacent cortex and white matter is important to prevent the misdiagnosis of oligodendroglioma, astrocytoma, or infiltrating glioma, not otherwise specified. Cortical ependymomas and angiocentric gliomas may comprise a group of locally infiltrative ependymal tumors that are associated with an excellent prognosis after gross total surgical resection.

Entities:  

Mesh:

Year:  2008        PMID: 18716554      PMCID: PMC2805172          DOI: 10.1097/NEN.0b013e31818521cd

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  21 in total

Review 1.  Tanycytes: morphology and functions: a review.

Authors:  J Flament-Durand; J P Brion
Journal:  Int Rev Cytol       Date:  1985

2.  The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases.

Authors:  L Palma; P Celli; A Mariottini; A Zalaffi; G Schettini
Journal:  Childs Nerv Syst       Date:  2000-03       Impact factor: 1.475

3.  Supratentorial ependymomas in adult patients.

Authors:  T H Schwartz; S Kim; R S Glick; E Bagiella; C Balmaceda; M R Fetell; B M Stein; M B Sisti; J N Bruce
Journal:  Neurosurgery       Date:  1999-04       Impact factor: 4.654

4.  CD99 immunoreactivity in ependymoma.

Authors:  Y L Choi; J G Chi; Y L Suh
Journal:  Appl Immunohistochem Mol Morphol       Date:  2001-06

5.  Fourth ventricle ependymomas. A study of 20 cases with survival analysis.

Authors:  L Ferrante; L Mastronardi; G Schettini; P Lunardi; A Fortuna
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 6.  Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation?

Authors:  Norman L Lehman
Journal:  J Neuropathol Exp Neurol       Date:  2008-03       Impact factor: 3.685

Review 7.  Cortical ependymoma. A case report and review.

Authors:  Norman L Lehman; Michelle A Jorden; Stephen L Huhn; Patrick D Barnes; Gregg B Nelson; Paul G Fisher; Dikran S Horoupian
Journal:  Pediatr Neurosurg       Date:  2003-07       Impact factor: 1.162

8.  Human ependymomas reveal frequent deletions on chromosomes 6 and 9.

Authors:  Bei Huang; Petr Starostik; Hannelore Schraut; Jürgen Krauss; Niels Sörensen; Wolfgang Roggendorf
Journal:  Acta Neuropathol       Date:  2003-07-24       Impact factor: 17.088

9.  Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma.

Authors:  Stefan Wolfsberger; Ingeborg Fischer; Romana Höftberger; Peter Birner; Irene Slavc; Karin Dieckmann; Thomas Czech; Herbert Budka; Johannes Hainfellner
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

10.  The cytogenetic basis for classifying ependymomas.

Authors:  R L Friede; A Pollak
Journal:  J Neuropathol Exp Neurol       Date:  1978 Mar-Apr       Impact factor: 3.685

View more
  9 in total

1.  Cortical ependymoma: an unusual epileptogenic lesion.

Authors:  Jamie J Van Gompel; Kelly K Koeller; Fredric B Meyer; W Richard Marsh; Peter C Burger; Federico Roncaroli; Gregory A Worrell; Caterina Giannini
Journal:  J Neurosurg       Date:  2011-01-14       Impact factor: 5.115

2.  Rapidly Enlarging Pediatric Cortical Ependymoma.

Authors:  Kouji Yamasaki; Kiyotaka Yokogami; Shinji Yamashita; Hideo Takeshima
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

3.  Supratentorial cortical ependymoma in a 21-month-old boy.

Authors:  Sang-Kook Lee; Dong-Jun Lim; Sang-Dae Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-09-30

4.  The Survival and Prognostic Factors of Supratentorial Cortical Ependymomas: A Retrospective Cohort Study and Literature-Based Analysis.

Authors:  Qiguang Wang; Jian Cheng; Jiuhong Li; Si Zhang; Wenke Liu; Yan Ju; Xuhui Hui
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 6.244

Review 5.  Classification and controversies in pathology of ependymomas.

Authors:  Catherine Godfraind
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

6.  Pure cortical ependymoma: A rare entity.

Authors:  Sanjay Bijwe; Sameer Ansari; Vinod Jadhav; Deepak Palande
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

7.  Supratentorial cortical ependymoma: An unusual presentation of a rare tumor.

Authors:  Mohammad Reza Mohaghegh; Ahmad Chitsaz; Ali Asghar Okhovat; Elnaz Babaei Pour
Journal:  Adv Biomed Res       Date:  2015-03-25

Review 8.  Supratentorial cortical ependymoma: A systematic literature review and case illustration.

Authors:  Joshua A Cuoco; Andrew C Strohman; Brittany M Stopa; Michael S Stump; John J Entwistle; Mark R Witcher; Adeolu L Olasunkanmi
Journal:  Rare Tumors       Date:  2022-07-08

9.  Supratentorial Pure Cortical Ependymoma: An Unusual Lesion Causing Focal Motor Aware Seizure.

Authors:  Manish Beniwal; Ajit Mishra; K V L Narasinga Rao; Vikas Vazhayil; Bevinahalli N Nandeesh; Sampath Somanna
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.